Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Colazide approved for ulcerative colitis maintenance in Europe

Sep. 17, 1999

Solvay scientists describe new motilin agonists derived from erythromycin

Sep. 16, 1999

rhIL-11 tested in active Crohn's disease

Sep. 16, 1999

XTL and Lilly to collaborate on HCV therapy research

Sep. 14, 1999

Isis and Abbott initiate collaboration for antisense drugs

Sep. 14, 1999

LEX-032, a recombinant serpin with beneficial effects on ischemia/reperfusion-induced pancreatitis

Sep. 13, 1999

New acylquinoline selected for development as antiulcer agent by Korean investigators

Sep. 13, 1999

Oxagen broadens collaboration in IBD research

Sep. 13, 1999

Synsorb Biotech searches for treatments for bacterial toxin-induced diseases

Sep. 13, 1999

New naturally occurring hepatoprotective/immunostimulating compound from Il Yang in phase II

Sep. 10, 1999

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...